Dr. Lal PathLabs informs about earnings call transcript

15 Nov 2021 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached Financial Results Conference Call Transcript of the Company for Q2 FY22.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

2934.60 -18.75 (-0.63%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7270.35
Max Healthcare Inst 1140.55
Narayana Hrudayalay 1307.35
Aster DM Healthcare 503.45
Global Health 1098.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.